ScoreWhy is Poseida Therapeutics, Inc. ?
1
With a growth in Net Profit of NAN%, the company declared Outstanding results in Sep 24
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD -15.02 MM
- DEBT-EQUITY RATIO (HY) Lowest at -169.85 %
- RAW MATERIAL COST(Y) Fallen by -16.31% (YoY)
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Poseida Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Poseida Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Poseida Therapeutics, Inc.
199.68%
0.65
307.15%
S&P 500
13.22%
0.61
20.23%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
173.08%
EBIT Growth (5y)
-3.35%
EBIT to Interest (avg)
-19.90
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.90
Sales to Capital Employed (avg)
0.56
Tax Ratio
0.07%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
64.23%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
10.62
EV to EBIT
-12.16
EV to EBITDA
-13.33
EV to Capital Employed
-9.66
EV to Sales
5.04
PEG Ratio
NA
Dividend Yield
92.45%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-69.67%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Poseida Therapeutics, Inc.
Net Sales
At USD 71.75 MM has Grown at 224.42%
over average net sales of the previous four periods of USD 22.12 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 20.28 MM has Grown at 171.99%
over average net sales of the previous four periods of USD -28.17 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 20.23 MM has Grown at 171.77%
over average net sales of the previous four periods of USD -28.19 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Debt-Equity Ratio
Lowest at -169.85 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Operating Cash Flow
Highest at USD -15.02 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 71.75 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 21.04 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 29.33 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 20.28 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 20.23 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.21
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -16.31% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Poseida Therapeutics, Inc.
Non Operating Income
Highest at USD 0.14 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
